List of Peer Reviewers (2007)
Is Disease Management Effective? Well...Some is.
Complementary and Alternative Medicine Provider Use and Expenditures by Cancer Treatment Phase
More than 26% of cancer patients see CAM providers, primarily for musculoskeletal problems; use does not vary by treatment phase, and associated expenditures are low.
The Cost of Treating Skeletal-Related Events in Patients With Prostate Cancer
The analysis examines the annual economic effect of medically treating patients with prostate cancer and subsequent bone metastases.
No Time to Waste: Decreasing Patient Wait Times for Chemotherapy Administration Using Automated Prioritization in an Oncology Pharmacy System
Using a prioritization algorithm in an oncology pharmacy system at the Johns Hopkins University, patient wait times for chemotherapy administration were significantly decreased.
Second-line and Third-line Chemotherapy for Lung Cancer: Use and Cost
Using health insurance claims, we identified common first-, second-, and third-line chemotherapy regimens for patients with lung cancer and associated utilization and costs of care.
Managed Care and Cancer Outcomes for Medicare Beneficiaries With Disabilities
This study showed better outcomes for disabled Medicare patients with breast cancer but not those with lung cancer when they were enrolled in HMOs.
The Effect of HEDIS Measurement of Colorectal Cancer Screening on Insurance Plans in Pennsylvania
In 2006, the NCQA began reporting colorectal cancer screening rates of member plans as a HEDIS measure, which is associated with Pennsylvania health system changes.
Cancer Screening Across the Aging Continuum
The article reviews the current state of knowledge regarding screening guidelines for older adults and gives recommendations for healthcare providers working with older adults.
Optimal Cancer Care Across the Spectrum of Life and Disease
The Guest Editors set the context for this special collection of oncology-focused articles.
2 Clarke Drive Cranbury, NJ 08512